Early research (Phase 1)UnknownNCT02134392What this trial is testingFecal Transplant for Pediatric Patients Who Have Recurrent C-diff InfectionWho this might be right forClostridium Difficile Jonathan Gisser 15
Large-scale testing (Phase 3)Study completedNCT03182907What this trial is testingBezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)Who this might be right forClostridium Difficile Infection Merck Sharp & Dohme LLC 148
Not applicableStudy completedNCT02770326What this trial is testingSafety of Stool Transplant for Patients With Difficult to Treat C. Difficile InfectionWho this might be right forC. Difficile InfectionCancer Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT02255305What this trial is testingFMT Versus Antimicrobials for Initial Treatment of Recurrent CDIWho this might be right forClostridium Difficile Infection Endeavor Health 6
Large-scale testing (Phase 3)Ended earlyNCT01887912What this trial is testingStudy of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile InfectionWho this might be right forClostridium Difficile Infection Sanofi Pasteur, a Sanofi Company 9,302
Testing effectiveness (Phase 2)Study completedNCT02299570What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile InfectionWho this might be right forEnterocolitis Clostridium Difficile Recurrent Rebiotix Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03617445What this trial is testingFecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant RecipientsWho this might be right forClostridium Difficile Infection Recurrence University of Wisconsin, Madison 3
Testing effectiveness (Phase 2)Study completedNCT03110133What this trial is testingEfficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffWho this might be right forClostridium Difficile Infection Recurrence Finch Research and Development LLC. 206
Not applicableWithdrawnNCT01472978What this trial is testingProspective Study of Clostridium Difficile in Children Undergoing ColonoscopyWho this might be right forC. Difficile Infection State University of New York at Buffalo
Testing effectiveness (Phase 2)Study completedNCT02148601What this trial is testingFecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile InfectionWho this might be right forClostridium Difficile Catholic University of the Sacred Heart 39
Early research (Phase 1)Not Yet RecruitingNCT05852587What this trial is testingXylitol Use for Decolonization of C. Difficile in Patients With IBDWho this might be right forInflammatory Bowel DiseasesClostridioides Difficile Infection Brigham and Women's Hospital 99
Early research (Phase 1)Study completedNCT01704937What this trial is testingFecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen InoculumWho this might be right forClostridium Difficile Infection Massachusetts General Hospital 20
Not applicableWithdrawnNCT01842347What this trial is testingTreatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)Who this might be right forClostridium Difficile Infection Medical College of Wisconsin
Post-approval studies (Phase 4)Active Not RecruitingNCT03663504What this trial is testingComparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon SurgeryWho this might be right forElective Colon Surgery Ottawa Hospital Research Institute 630
Large-scale testing (Phase 3)UnknownNCT02466698What this trial is testingIntestinal Lavage for the Treatment of Severe C. Difficile InfectionsWho this might be right forClostridium Difficile London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Testing effectiveness (Phase 2)Study completedNCT00382304What this trial is testingThe Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaWho this might be right forPseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea Genzyme, a Sanofi Company 24
Post-approval studies (Phase 4)Ended earlyNCT04626947What this trial is testingPrevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).Who this might be right forInflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more David Binion, MD 19
Large-scale testing (Phase 3)Study completedNCT03931941What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)Who this might be right forClostridium Difficile InfectionInfectionCommunicable Diseases Rebiotix Inc. 793
Not applicableStudy completedNCT02375477What this trial is testingImproved Adherence to C. Difficile Isolation Protocols Through Improved Education MethodsWho this might be right forBacterial InfectionClostridium Difficile Case Comprehensive Cancer Center 38
Not applicableStudy completedNCT06669936What this trial is testingRescue FMT with Bezlotoxumab for Recurrent C. Difficile InfectionWho this might be right forRecurrent C. Difficile Infection Alexander Khoruts 24